Tumor-associated macrophage or chemokine ligand CCL17 positively regulates the tumorigenesis of hepatocellular carcinoma

详细信息    查看全文

• 作者：Fangyu Zhu ; Xiangnan Li ; Siyu Chen ; Qiu Zeng ; Yu Zhao ; Fang Luo
• 关键词：Hepatocellular carcinoma ; Tumor ; associated macrophage ; Epithelial–mesenchymal transition ; Wnt/β ; catenin signaling
• 刊名：Medical Oncology
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：33
• 期：2
• 全文大小：8,982 KB
• 参考文献：1.Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29. doi:10.​3322/​caac.​21208 .CrossRef PubMed
  2.El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365(12):1118–27. doi:10.​1056/​NEJMra1001683 .CrossRef PubMed
  3.Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–44. doi:10.​1038/​nature07205 .CrossRef PubMed
  4.Germano G, Frapolli R, Belgiovine C, Anselmo A, Pesce S, Liguori M, et al. Role of macrophage targeting in the antitumor activity of trabectedin. Cancer Cell. 2013;23(2):249–62. doi:10.​1016/​j.​ccr.​2013.​01.​008 .CrossRef PubMed
  5.Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. 2004;4(7):540–50. doi:10.​1038/​nrc1388 .CrossRef PubMed
  6.Yeung OW, Lo CM, Ling CC, Qi X, Geng W, Li CX, et al. Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma. J Hepatol. 2015;62(3):607–16. doi:10.​1016/​j.​jhep.​2014.​10.​029 .CrossRef PubMed
  7.Barashi N, Weiss ID, Wald O, Wald H, Beider K, Abraham M, et al. Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice. Hepatology. 2013;. doi:10.​1002/​hep.​26403 .
  8.Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem. 1997;272(23):15036–42.CrossRef PubMed
  9.Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25(12):677–86. doi:10.​1016/​j.​it.​2004.​09.​015 .CrossRef PubMed
  10.Li CM, Hou L, Zhang H, Zhang WY. CCL17 induces trophoblast migration and invasion by regulating matrix metalloproteinase and integrin expression in human first-trimester placenta. Reprod Sci. 2014;. doi:10.​1177/​1933719113519170​ .
  11.Zhu F, Jiang Y, Luo F, Li P. Effectiveness of localized ultrasound-targeted microbubble destruction with doxorubicin liposomes in H22 mouse hepatocellular carcinoma model. J Drug Target. 2015;. doi:10.​3109/​1061186X.​2014.​996759 .PubMedCentral
  12.Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology. 2006;44(1):240–51. doi:10.​1002/​hep.​21227 .CrossRef PubMed
  13.Naito S, von Eschenbach AC, Giavazzi R, Fidler IJ. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res. 1986;46(8):4109–15.PubMed
  14.Wands JR, Kim M. WNT/beta-catenin signaling and hepatocellular carcinoma. Hepatology. 2014;60(2):452–4. doi:10.​1002/​hep.​27081 .CrossRef PubMed
  15.Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell. 2012;149(6):1192–205. doi:10.​1016/​j.​cell.​2012.​05.​012 .CrossRef PubMed
  16.MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17(1):9–26. doi:10.​1016/​j.​devcel.​2009.​06.​016 .PubMedCentral CrossRef PubMed
  17.Imai T, Nagira M, Takagi S, Kakizaki M, Nishimura M, Wang J, et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol. 1999;11(1):81–8.CrossRef PubMed
  18.Ishitsuka K, Tamura K. Human T-cell leukaemia virus type I and adult T-cell leukaemia–lymphoma. Lancet Oncol. 2014;15(11):e517–26. doi:10.​1016/​S1470-2045(14)70202-5 .CrossRef PubMed
  19.Lee JH, Cho YS, Lee JY, Kook MC, Park JW, Nam BH, et al. The chemokine receptor CCR4 is expressed and associated with a poor prognosis in patients with gastric cancer. Ann Surg. 2009;249(6):933–41. doi:10.​1097/​SLA.​0b013e3181a77ccc​ .CrossRef PubMed
  20.Li JY, Ou ZL, Yu SJ, Gu XL, Yang C, Chen AX, et al. The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer. Breast Cancer Res Treat. 2012;131(3):837–48. doi:10.​1007/​s10549-011-1502-6 .CrossRef PubMed
  21.Zhao Z, Lu P, Zhang H, Xu H, Gao N, Li M, et al. Nestin positively regulates the Wnt/beta-catenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells. BCR. 2014;16(4):408. doi:10.​1186/​s13058-014-0408-8 .PubMedCentral CrossRef PubMed
  22.Pickup M, Novitskiy S, Moses HL. The roles of TGFbeta in the tumour microenvironment. Nat Rev Cancer. 2013;13(11):788–99. doi:10.​1038/​nrc3603 .PubMedCentral CrossRef PubMed
  23.Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial–mesenchymal transitions in development and disease. Cell. 2009;139(5):871–90. doi:10.​1016/​j.​cell.​2009.​11.​007 .CrossRef PubMed
  24.Itoh F, Watabe T, Miyazono K. Roles of TGF-beta family signals in the fate determination of pluripotent stem cells. Semin Cell Dev Biol. 2014;32:98–106. doi:10.​1016/​j.​semcdb.​2014.​05.​017 .CrossRef PubMed
  25.Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial–mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178–96. doi:10.​1038/​nrm3758 .PubMedCentral CrossRef PubMed
  26.Magee JA, Piskounova E, Morrison SJ. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell. 2012;21(3):283–96. doi:10.​1016/​j.​ccr.​2012.​03.​003 .PubMedCentral CrossRef PubMed
  27.Yang ZF, Ngai P, Ho DW, Yu WC, Ng MN, Lau CK, et al. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology. 2008;47(3):919–28. doi:10.​1002/​hep.​22082 .CrossRef PubMed
  28.Kahn M. Can we safely target the WNT pathway? Nat Rev Drug Discov. 2014;13(7):513–32. doi:10.​1038/​nrd4233 .PubMedCentral CrossRef PubMed
  
• 作者单位：Fangyu Zhu (1) (2)
  Xiangnan Li (2)
  Siyu Chen (1)
  Qiu Zeng (1)
  Yu Zhao (1)
  Fang Luo (2)
  
  1. Department of Vascular Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People’s Republic of China
  2. Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People’s Republic of China
  
• 刊物主题：Oncology; Hematology; Pathology; Internal Medicine;
• 出版者：Springer US
• ISSN：1559-131X

文摘

Alternatively activated macrophages (M2) can secrete chemokines, such as chemokine ligand 17 (CCL17), and are associated with promoting tumorigenesis of hepatocellular carcinoma (HCC). This study aimed at investigating the potential role of M2 and CCL17 in progression of HCC. The levels of CCL17 expression in 90 HCC samples were characterized by tissue microarray and stratified for the postsurgical survival. MHCC97L cells were co-cultured with classically activated M1, M2 or CCL17-silencing M2ccl17mute or treated with conditional medium (CM) from these cells or CCL17 in vitro. The wound healing, invasion, viability and apoptosis of MHCC97L cells in vitro and tumor growth in vivo were determined. The stemness of MHCC97L cells was examined by sphere formation, flow cytometry and Western blot. The relative expression levels of epithelial–mesenchymal transition (EMT) factors and the Wnt/β-catenin signaling were determined. Higher levels of intratumoral CCL17 expression were significantly associated with clinical pathological characteristics of HCC and with poorer overall survival rates in HCC patients (P < 0.05). High levels of CCR4 were detected in MHCC97L cells. Treatment with the CM from M2 or with CCL17 significantly enhanced the wound healing process, invasion and proliferation of MHCC97L cells in vitro. Co-implantation MHCC97L cells with M2 significantly promoted the growth of MHCC97L tumors in vivo. Co-culture with M2 or treatment with CCL17 enhanced the stemness, EMT process, the TGF-β1 and Wnt/β-catenin signaling in MHCC97L cells. CCL17 promotes the tumorigenesis of HCC and may be a potential biomarker and target for HCC prognosis and therapy.